Tolerance to autoantigen

Current Opinion in Organ Transplantation

Volumn 9, Issue 3, 2004, Pages 246-251

  Sumpter, Tina L ^a   Wilkes, David S ^a  

^a INDIANA UNIVERSITY   (United States)

Author keywords

Autoimmunity; Molecular mimicry; Organ transplantation; Regulatory T cells; Tolerance

Indexed keywords

EID: 17844385644     PISSN: 10872418     EISSN: 15317013     Source Type: Journal    
DOI: 10.1097/01.mot.0000129651.80629.ae     Document Type: Review

References (62)

1. Morgun A, Shulzhenko N, Unterkircher C, et al.: Pre- and post-transplant antimyosin and anti-heat shock protein antibodies and cardiac transplant outcome. J Heart Lung Transplant 2004, 23:204-209.
2. Ramji A, Owen D, Erb S, et al.: Post-liver transplant Crohn's disease graft tolerance but not self-tolerance. Dig Dis Sci 2003, 47:522-527.
3. Valujskikh A, Fedoseyeva E, Benichou G, et al.: Development of autoimmunity after skin graft rejection via an indirect alloresponse. Transplantation 2002, 73:1130-1137.
4. Birk O, Gur S, Elias D, et al.: The 60-kDa heat shock protein modulates allograft rejection. PNAS 1999, 96:5159-5163.
5. Haque MA, Mizobuchi T, Yasufuku K, et al.: Evidence for immune responses to a self-antigen in lung transplantation: role of type V collagen-specific T cells in the pathogenesis of lung allograft rejection. J Immunol 2002, 169:1542-1549.
6. Pearson T, Markees T, Serreze D, et al.: Islet cell autoimmunity and transplantation tolerance: two distinct mechanisms. Ann NY Acad Sci 2003, 1005:148-156.
7. Benichou G, Valujskikh A, Heeger P: Contributions of direct and indirect T cell alloreactivity during allograft rejection in mice. J Immunol 1999, 162:352-358.
8. Duncan SR, Leonard C, Theodore J, et al.: Oligoclonal CD4+ T cell expansions in lung transplant recipients with obliterative bronchiolitis. Am J Respir Crit Care Med 2002, 165:1439.
9. Halloran PF, Homik J, Goes N, et al.: The 'injury response': A concept linking nonspecific injury, acute rejection, and long-term transplant outcomes. Transplant Proc 1997, 29:79-81.
10. Fedoseyeva E, Zhang F, Orr P, et al.: De novo autoimmunity to cardiac myosin after heart transplantation and its contribution to the rejection process. J Immunol 1999, 162:6836-6842.
11. Anderson AC, Kuchroo, Vijay K: Expression of self-antigen in the thymus: a little goes a long way. J Exp Med 2003, 198:1627-1629.
12. Gotter J, Brors B, Hergenhahn M, et al.: Medullary epithelial cells of the human thymus express a highly diverse selection of tissue-specific genes colocalized in chromosomal clusters. J Exp Med 2004, 199:155-166.
13. Palmer E: Negative selection-clearing out the bad apples from the T-cell repertoire. Nature Rev Immunol 2003, 3:383-391.
14. Uchida D, Hatakeyama S, Matsushima A, et al.: AIRE functions as an E3 ubiquitin ligase. J Exp Med 2004, 199:167-172.
15. Vanderlugt C, Miller S: Epitope spreading in immune-mediated disease: implication for immunotherapy. Nature Rev Immunol 2002, 2:85-95.
16. Doyle H, Gee R, Mamula M: A failure to repair self-proteins leads to T cell hyperproliferation and autoantibody production. J Immunol 2003, 171:2840-2847.
17. Greidinger EL, Foecking MF, Magee J, et al.: A major B cell epitope present on the apoptotic but not the intact form of the U1-70-kDa ribonucleoprotein autoantigen. J Immunol 2004, 172:709-716.
18. Takahashi T, Kuniyasu Y, Toda M, et al.: Immunological self-tolerance maintained by CD25+CD4+ naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic state. Int Immunol 1998, 10:1969-1980.
19. Piccirillo C, Shevach E: Control of CD8+ T cell activation by CD4+CD25+ immunoregulatory cells. J Immunology 2001, 167:1137-1140.
20. Azuma T, Takahashi T, A AK, et al.: Human CD4+CD25+ regulatory T cells suppress NKT function. Cancer Res 2003, 63:4516-4520.
21. Thornton AM, Shevach EM: CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998, 188:287-296.
22. Sakaguchi S, Sakaguchi N, Asano M, et al.: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 155:1151-1164.
23. Filaci G, Suciu-Foca N: CD8+ T suppressor cells are back to the game: are they players in autoimmunity? Autoimmunity Rev 2002, 1:279-283.
24. Chen W, Ford MS, Young KJ, et al.: Role of double-negative regulatory T cells in long-term cardiac xenograft survival. J Immunol 2003, 170:1846-1853.
25. Bluestone J, Abbas A: Natural versus adaptive regulatory T cells. Nature Rev Immunol 2003, 3:253-257.
26. Levings MK, Sangregorio R, Sartirana C, et al.: Human CD25+CD4+ T suppressor cell clones produce transforming growth factor {beta}, but not interleukin 10, and are distinct from type 1 T regulatory cells. J Exp Med 2002, 196:1335-1346.
27. Graca L, Thompson S, Lin C-Y, et al.: Both CD4+CD25+ and CD4+CD25- regulatory cells mediate dominant transplantation tolerance. J Immunol 2002, 168:5558-5564.
28. Dai Z, Li Q, Wang Y, et al.: CD4+CD25+ regulatory T cells suppress allograft rejection mediated by memory CD8+ T cells via a CD30-dependent mechanism. J Clin Invest 2004, 113:310-317.
29. McHugh R, Whitters M, Piccirillo C, et al.: CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoidinduced TNF receptor. Immunity 2002, 16:311-323.
30. Fu S, Yopp AC, Mao X, et al.: CD4+CD25+CD62+ T-regulatory cell subset has optimal suppressive and proliferative potential. Am J Transplant 2004, 4:65-78.
31. Powrie F, Correa-Oliveira R, Mauze S, et al.: Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell-mediated immunity. J Exp Med 1994, 179:589-600.
32. Alyanakian M-A, You S, Damotte D, et al.: Diversity of regulatory CD4+T cells controlling distinct organ-specific autoimmune diseases. PNAS 2003, 100:15806-15811.
33. Schubert L, Jeffrey E, Zhang Y, et al.: Scurfin (Foxp3) acts as a repressor of transcription and regulates T cell activation. J Biol Chem 1999, 40:37672-37679.
34. Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
35. Thornton A, Shevach EM: Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen non-specific. J Immunol 2000, 164:183-190.
36. Zheng SG, Gray JD, Ohtsuka K, et al.: Generation ex vivo of TGF-{beta}- producing regulatory T cells from CD4+CD25- precursors. J Immunol 2002, 169:4183-4189.
37. Walker LSK, Chodos A, Eggena M, et al.: Antigen-dependent proliferation of CD4+ CD25+ regulatory T cells in vivo. J Exp Med 2003, 198:249-258.
38. Koenen HJ, Fasse E, Joosten I: IL-15 and cognate antigen successfully expand de novo-induced human antigen-specific regulatory CD4+ T cells that require antigen-specific activation for suppression. J Immunol 2003, 171:6431-6441.
39. Cookson S, Doherty D, Todryk S, et al.: Hepatic expression of IL-15 mRNA is associated with liver graft acceptance. Transplant Immunol 2003, 11:39-48.
40. Stassen M, Schmitt E, Jonuleit H: Human CD4+CD25+ regulatory T cells and infectious tolerance. Transplantation 2004, 77:S23-S25.
41. Chen W, Jin W, Hardegen N, et al.: Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-{beta} induction of transcription factor Foxp3. J Exp Med 2003, 198:1875-1886.
42. Zheng SG, Wang JH, Koss MN, et al.: CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-{beta} suppress a stimulatory graftversus-host disease with a lupus-like syndrome. J Immunol 2004, 172:1531-1539.
43. Lohr J, Knoechel B, Sharpe AH, et al.: The inhibitory function of B7 costimulators in T cell responses to foreign and self-antigens. Nature Immunol 2003, 4:664-669.
44. Jin Y, Fuller L, Ciancio G, et al.: Antigen presentation and immune regulatory capacity of immature and mature-enriched antigen presenting (dendritic) cells derived from human bone marrow. Hum Immunol 2004, 65:93-103.
45. Jiang S, Camara N, Lombardi G, et al.: Induction of allopeptide-specific human CD4+CD25+ regulatory T cells ex vivo. Blood 2003, 102:2180-2186.
46. Higgins S, Lavelle E, McCann C, et al.: Toll-like receptor 4-mediated innate IL-10 activates antigen-specific regulatory T cells and confers resistance to Bordetella pertussis by inhibiting inflammatory pathology. J Immunol 2003, 171:3119-3127.
47. Yamazaki S, Iyoda T, Tarbell K, et al.: Direct expansion of functional CD25+ CD4+ regulatory T cells by antigen-processing dendritic cells. J Exp Med 2003, 198:235-247.
48. Sato K, Yamashita N, Baba M, et al.: Modified myeloid dendritic cells act as regulatory dendritic cells to induce anergic and regulatory T cells. Blood 2003, 101:3581-3589.
49. Gregori S, Casorati M, Amuchastegui S, et al.: Regulatory T cells induced by 1a,25-dihydroxyvitamin D3 and mycophenolate mofetil treatment mediate transplantation tolerance. J Immunol 2001, 167:1945-1953.
50. Adorini L: Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting autoimmune diabetes. Ann N Y Acad Sci 2003, 987:258-261.
51. Scheinecker C, McHugh R, Shevach E, et al.: Constitutive presentation of a natural tissue autoantigen exclusively be dendritic cells in the draining lymph node. J Exp Med 2002, 196:1079-1090.
52. Amedei A, Bergman MP, Appelmelk BJ, et al.: Molecular mimicry between Helicobacter pylori antigens and H+,K+-adenosine triphosphatase in human gastric autoimmunity. J Exp Med 2003, 198:1147-1156.
53. Ciubotariu R, Liu Z, Colovai AI, et al.: Persistent allopeptide reactivity and epitope spreading in chronic rejection of organ allografts. J Clin Invest 1998, 101:398-405.
54. Billings JL, Hertz MI, Savik K, et al.: Respiratory viruses and chronic rejection in lung transplant recipients1. J Heart Lung Transplant 2002, 21:559-566.
55. Adams AA, William MA, Jones SR, et al.: Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003, 111:1887-1895.
56. McClain MT, Lutz CS, Kaufman KM, et al.: Structural availability influences the capacity of autoantigenic epitopes to induce a widespread lupus-like autoimmune response. PNAS 2004, 101:3551-3556.
57. Cremer M, Rosloniec E, Kang A: The cartilage collagens: a review of their structure, organization, and role in the pathogenesis of experimental arthritis in animals and in human rheumatic disease. J Mol Med 1998, 76:275-288.
58. Liu B, Dai J, Zheng H, et al.: Cell surface expression of an endoplasmic reticulum resident heat shock protein gp96 triggers MyD88-dependent systemic autoimmune diseases. PNAS 2003, 100:15824-15829.
59. Chen K, Lu J, Wang L, et al.: Mycobacterial heat shock protein 65 enhances antigen cross-presentation in dendritic cells independent of Toll-like receptor 4 signaling. J Leuk Biol 2004, 75:260-266.
60. Pasare C, Medzhitov R: Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003, 299:1033-1036.
61. Mahnke K, Knop J, Enk A: Induction of tolerogenic DCs: 'you are what you eat'. Trends Immunol 2003, 24:646-651.
62. Waldmann H: Reprogramming the immune system. Immunol Rev 2002, 185:227-235.